JEV-84044-22368
3 vaccinations
2 coded responses
29 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 480 / MI
- Registered
- 2021-05-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
B4P-21763-58648
Child or adolescent in my care · Female · 2022-12-29
Timeline
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Registered in v-safe
-
2021-05-04
Dose 2 — Pfizer-BioNTech
- 2021-05-04
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-06
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Balance disorder, Dizziness — Feeling: Fair · Site: Pain · HeadacheFree text: Light headed and balance issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
- 2021-05-11
- 2021-05-18
- 2021-05-27
- 2021-06-03
- 2021-06-08
- 2021-06-15
- 2021-08-05
- 2021-11-02
-
2021-11-16
Dose 3 — Pfizer-BioNTech
- 2021-11-16
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-12-02
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
-
2022-02-15
Survey response — 3 months, dose 3MedDRA: Fatigue, Headache, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Headache, tired, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-19
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-05-04 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Light headed and balance issues
Release 11 — 3 months, dose 3
Symptoms: Headache, tired, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Balance disorder | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release